H

HilleVax

61 employees

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Biopharma

Date founded

2021

Funding rounds raised

Total raised

$135M

from 9 investors over 9 rounds

H

HilleVax raised $135M on September 8, 2021

Investors: Greenspring Associates, Qiming Venture Partners USA, Sahsen Ventures, LLC, Frazier Healthcare Partners, Richard King Mellon Foundation, Samsara BioCapital, Perceptive Advisors, Lightspeed Venture Partners and RA Capital Management, L.P.

FAQ